The primary objectives of this study were to investigate differential binding of Scg3 to individual intraretinal vasculatures in diabetic versus non-diabetic mice, compare binding patterns with those of VEGF, and relate the binding to endothelial dysfunction and disease-targeted therapy with anti-Scg3 antibodies. The gene discussed is SCG3; the disease is endothelial dysfunction.